\documentclass[12pt]{article}
% \usepackage[top=1in,left=1in, right = 1in, footskip=1in]{geometry}
\usepackage[top=1in,footskip=1in]{geometry}

\usepackage{graphicx}
\usepackage{xspace}
%\usepackage{adjustbox}

\newcommand{\comment}{\showcomment}
%% \newcommand{\comment}{\nocomment}

\newcommand{\showcomment}[3]{\textcolor{#1}{\textbf{[#2: }\textsl{#3}\textbf{]}}}
\newcommand{\nocomment}[3]{}

\newcommand{\jd}[1]{\comment{cyan}{JD}{#1}}
\newcommand{\swp}[1]{\comment{magenta}{SWP}{#1}}
\newcommand{\bmb}[1]{\comment{blue}{BMB}{#1}}
\newcommand{\djde}[1]{\comment{red}{DJDE}{#1}}

\newcommand{\eref}[1]{Eq.~(\ref{eq:#1})}
\newcommand{\fref}[1]{Fig.~\ref{fig:#1}}
\newcommand{\Fref}[1]{Fig.~\ref{fig:#1}}
\newcommand{\sref}[1]{Sec.~\ref{#1}}
\newcommand{\frange}[2]{Fig.~\ref{fig:#1}--\ref{fig:#2}}
\newcommand{\tref}[1]{Table~\ref{tab:#1}}
\newcommand{\tlab}[1]{\label{tab:#1}}
\newcommand{\seminar}{SE\mbox{$^m$}I\mbox{$^n$}R}

\usepackage{amsthm}
\usepackage{amsmath}
\usepackage{amssymb}
\usepackage{amsfonts}
\usepackage[utf8]{inputenc} % make sure fancy dashes etc. don't get dropped

\usepackage{lineno}
\linenumbers

\usepackage[pdfencoding=auto, psdextra]{hyperref}

\usepackage{natbib}
\bibliographystyle{unsrt}
\date{\today}

\usepackage{xspace}
\newcommand*{\ie}{i.e.\@\xspace}

\usepackage{color}

\newcommand{\Rx}[1]{\ensuremath{{\mathcal R}_{#1}}\xspace} 
\newcommand{\RR}{\ensuremath{{\mathcal R}}\xspace}
\newcommand{\Rres}{\Rx{\mathrm{res}}}
\newcommand{\Rinv}{\Rx{\mathrm{inv}}}
\newcommand{\Rhat}{\ensuremath{{\hat\RR}}}
\newcommand{\Rt}{\ensuremath{{\mathcal R}(t)}\xspace}
\newcommand{\tsub}[2]{#1_{{\textrm{\tiny #2}}}}
\newcommand{\dd}[1]{\ensuremath{\, \mathrm{d}#1}}
\newcommand{\dtau}{\dd{\tau}}
\newcommand{\dx}{\dd{x}}
\newcommand{\dsigma}{\dd{\sigma}}

\newcommand{\rx}[1]{\ensuremath{{r}_{#1}}\xspace} 
\newcommand{\rres}{\rx{\mathrm{res}}}
\newcommand{\rinv}{\rx{\mathrm{inv}}}

\newcommand{\psymp}{\ensuremath{p}} %% primary symptom time
\newcommand{\ssymp}{\ensuremath{s}} %% secondary symptom time
\newcommand{\pinf}{\ensuremath{\alpha_1}} %% primary infection time
\newcommand{\sinf}{\ensuremath{\alpha_2}} %% secondary infection time

\newcommand{\psize}{{\mathcal P}} %% primary cohort size
\newcommand{\ssize}{{\mathcal S}} %% secondary cohort size

\newcommand{\gtime}{\tau_{\rm g}} %% generation interval
\newcommand{\gdist}{g} %% generation-interval distribution
\newcommand{\idist}{\ell} %% incubation-period distribution

\newcommand{\total}{{\mathcal T}} %% total number of serial intervals

\usepackage{lettrine}

\newcommand{\dropcapfont}{\fontfamily{lmss}\bfseries\fontsize{26pt}{28pt}\selectfont}
\newcommand{\dropcap}[1]{\lettrine[lines=2,lraise=0.05,findent=0.1em, nindent=0em]{{\dropcapfont{#1}}}{}}

\begin{document}

\begin{flushleft}{
	\Large
	\textbf\newline{
		Epidemic dynamics shape inferences of the differences in incubation-period and generation-interval distributions of the Delta and Omicron variants
	}
}
\bigskip

\section*{Abstract}

Estimating the differences in the incubation-period and serial-interval distributions of SARS-CoV-2 variants is critical to understanding changes in their transmission dynamics and therefore controlling their outbreaks.
However, these comparisons are inherently difficult due to their dependence on epidemic growth rates---for example, when an epidemic is growing exponentially, a cohort of infected individuals who developed symptoms at the same time are more likely to have shorter incubation periods.
Here, we re-analyze incubation-period and serial-interval data collected by Backer \textit{et al.}, describing transmissions of the Delta and Omicron variants from Netherlands at the end of December 2021.
Previous analysis of the same data set reported shorter mean observed incubation period (3.2 days vs 4.4 days) and serial interval (3.5 days vs 4.1 days) for the Omicron variant, but the number of infections caused by the Delta variant decreased during this period as the number of Omicron infections increased.
When we account for growth-rate differences of two variants, we estimate similar mean incubation periods (3.8--4.5 days) for both variants but a shorter mean generation interval for the Omicron variant (3.3 days; 95\% CI: 2.8--3.7 days) than for the Delta variant (4.2 days; 95\% CI: 4.0--4.4 days).
The differences in generation intervals may reflect higher reproduction numbers of the Omicron variant, which can drive faster susceptible depletion among close contacts.
Neglecting differences in the generation-interval distributions can further bias in estimates of transmission advantages of the Omicron variant.

\end{flushleft}

\pagebreak

\section{Introduction}

Estimating transmission advantages of new SARS-CoV-2 variants is critical to predicting and controlling the course of the ongoing COVID-19 pandemic.
Transmission advantages of invading variants are typically characterized by the ratios of reproduction numbers, $\Rinv/\Rres$, and the differences in growth rates, $\rinv-\rres$.
These two quantities are linked by the generation-interval distributions of the resident and invading variants.
For example, an invading variant with shorter generation intervals---defined as the time between infection of the infector and the infectee---will exhibit faster epidemic growth ($\rinv > \rres > 0$) even if their reproduction numbers are identical ($\Rinv = \Rres > 1$).

Estimating generation-interval is hard, largely due to difficulties in observing actual infection events.
Many researchers primarily focus on comparisons of other transmission intervals, such as time between symptom onsets (also referred to as serial intervals) or between testing events \citep{abbott2022test} of the infector and the infectee.
However, transmission-interval distributions are subject to dynamical effects which can bias estimation.
For example, when the epidemic is growing, a cohort of infectors who developed symptoms at the same time are more likely to have been infected recently, shortening their incubation periods---in other words, their incubation periods will be shorter, on average, than those of their infectees, causing the mean serial interval to be longer than the mean generation interval \citep{park2021forward}.
Therefore, observed differences in transmission-interval distributions between variants can give a biased picture of true differences in their generation-interval distributions, especially if their growth rates differ.

Here, we re-analyze serial-interval data collected by \citep{backer2021omicron}, representing within- and between-household transmissions of the Delta and Omicron variants from the Netherlands between 13 and 26 December 2021.
The authors of the original article reported shorter serial intervals (3.5 vs 4.1 days) and incubation periods (3.2 vs 4.4 days) for transmission pairs with S-gene target failure (mostly omicron during the study period) and without (mostly delta), but did not consider growth-rate differences in their inference.
Here, we discuss the epidemiological context in the Netherlands during the study period and take dynamics into account to provide corrected estimates for the incubation periods and generation-interval distributions of the Delta and Omicron variants.

\section{Methods}

\subsection{Data}

We analyze time series of reported COVID-19 cases (\url{https://data.rivm.nl/covid-19/}) and proportions of SARS-CoV-2 variants detected (\url{https://www.rivm.nl/coronavirus-covid-19/virus/varianten}) from the Netherlands between 29 November 2021 and 30 January 2022.
Both data are publicly available on the National Institute for Public Health and the Environment (RIVM) website.

Serial interval data are taken from the supplementary material of \cite{backer2021omicron}.
The data are aggregated by the length of the serial interval in days and do not include additional individual-level information, such as exposure dates or symptom onset dates.
The data consists of 2529 transmission pairs and are further stratified by the presence of S gene target failure (SGTF), week of infectors' symptom onset date (weeks 50 and 51), and the type of transmission (within or between households).
In the main text, we combine data from weeks 50 and 51 and instead present a stratified analysis in Supplementary Material.
For simplicity, we refer to transmission pairs with and without SGTFs as Omicron and Delta transmission pairs, respectively.
Incubation period data are not publicly available with the original article; instead, we rely on previous estimates by \cite{backer2021omicron} to derive growth-rate-adjusted incubation-period distributions.
See original article for details of data collection.

\subsection{Estimating epidemic growth rates}

To estimate the differences in growth rates of the Delta and Omicron variants, we first estimate the number of COVID-19 cases caused by each variant by multiplying reported weekly numbers of cases by the proportion of Delta and Omicron variants detected---we use weekly time series to smooth over patterns of testing and reporting within each week. 
We then fit a generalized additive model \citep{wood2001mgcv} to to the logged weekly case estimates to obtain smooth trajectories for case time series.
%% More specifically, we model the logged weekly numbers of cases caused by each variant as a function of time using a shrinkage version of a cubic spline with restricted maximum likelihood.
%% JD: clarified previous s. Don't think we need this, with the cite.
Finally, we take the derivative of the predicted logged numbers of cases caused by each variant to obtain time-varying growth rate estimates.

To obtain confidence intervals on the estimated time-varying growth rates, we generate 1000 parameter sets by resampling spline coefficients from a multivariate normal distribution using the estimated variance-covariance matrices.
We calculate time-varying growth rates from each parameter set and use equi-tailed quantiles to generate 95\% confidence limits. 

\subsection{Estimating forward incubation-period distributions from backward incubation-period distributions}

\cite{backer2021omicron} estimated the incubation periods from 513 individuals (258 Omicron and 255 Delta cases), with symptom onsets between 1 December 2021 and 2 January 2022.
They used the methods of \cite{backer2020incubation}, which estimates incubation period by inferring distributions of time of infection for each individual from their known exposure dates, using a uniform distribution, and compares this to a known symptom-onset time.

In practice, incubation periods (and other epidemiological delays) can be measured in two ways: forward and backward.
The forward incubation periods are measured from a cohort of individuals who were infected at the same time. 
We expect this forward incubation-period distribution $f_I(\tau)$ to remain constant over the course of an epidemic and provide reliable estimates of the distribution across individuals. 
Backward incubation periods are measured from a cohort of individuals who developed symptoms at the same time. 
We expect the backward incubation-period distribution to be sensitive to epidemic dynamics.
The difference arises because forward incubation periods look forward from the reference point towards symptom development, which is an individual-level process, while backward incubation periods look backwards towards an infection event, which requires an interaction with an infectious individual.

In particular, when incidence of infection is growing exponentially, we are more likely to observe shorter backward incubation periods because there will be relatively more individuals who were infected recently.
Specifically, the backward incubation-period distribution $b_I(\tau)$ corresponds to:
\begin{equation}
b_I(\tau) =\frac{ \exp(-r\tau) f_I(\tau)}{\int_0^\infty \exp(-r x) f_I(x)  \dx},
\label{eq:backward}
\end{equation}
where $r$ represents the epidemic growth rate.
The method of \cite{backer2020incubation} starts from observed symptom onsets, and estimates the backward incubation-period distribution without taking growth rates into account.

For a given growth rate $r$, the corresponding forward incubation-period distributions can be calculated by inverting \eref{backward}:
\begin{equation}
f_I(\tau) = \frac{\exp(r\tau) b_I(\tau) }{\int_0^\infty \exp(rx) b_I(x)\dx}.
\label{eq:forward}
\end{equation}
Since incubation-period data are not provided, we are not able to fit \eref{forward} directly; 
instead we take the backward incubation-period distributions $b_I(x)$ estimated by \cite{backer2021omicron}, which was originally assumed to follow a Weibull distribution, and apply \eref{forward}.
In particular, \cite{backer2021omicron} estimated the scale and shape parameters of the Weibull distribution to be 4.93 (95\% CI: 4.51--5.37) and 1.83 (95\% CI: 1.59--2.08), respectively, for the non-SGTF cases, and 3.60 (95\% CI: 3.23--3.98) and 1.50 ((95\% CI: 1.32--1.70), respectively, for SGTF cases.

We also model the backward incubation-period distribution $b_I(\tau)$ using a Weibull distribution based on the assumptions of \cite{backer2021omicron}.
To account for uncertainties in the original parameter estimates, we rely on a sampling scheme, similar to the one we used for the growth rate analysis (in Section 2.2).
First, we approximate the previously inferred posterior distributions of the shape and scale parameters of the Weibull distribution using a lognormal distribution---we parameterize the lognormal distribution such that (i) its median matches the median of the posterior distributions and (ii) the probability that a random variable following the specified lognormal distribution falls between the lower and upper credible limits matches 95\% \citep{park2020reconciling}.
We draw 1000 samples of the shape and scale parameters (for the backward distribution $b_I(\tau)$) from the specified lognormal distributions and estimate the corresponding forward distribution using \eref{forward}.
We take 95\% equi-tailed quantiles to obtain 95\% confidence intervals.

\subsection{Estimating forward generation-interval distributions from forward serial-interval distributions}

Dynamical biases in the serial-interval distributions are more complex because the serial interval depends on the incubation periods of the infector and the infectee as well as the generation interval between them.
For example, \cite{backer2021omicron} measured the forward serial-interval distributions from cohorts of infectors who developed symptoms during the same week.
In this case, the forward serial interval $\tau_s$ can be expressed in the form \citep{park2021forward}:
\begin{equation}
\tau_s =  - \tau_{i, 1} + \tau_{g, \mathrm{symp}} + \tau_{i, 2},
\label{eq:serial}
\end{equation}
where $\tau_{i, 1}$ represents the backward incubation period of the infector (because all infectors developed symptoms at the same time), and $\tau_{i, 2},$ represents the forward incubation period of the infectee.
Here, $\tau_{g, \mathrm{symp}}$ represents the generation interval between the infector and the infectee; we use the subscript $\mathrm{symp}$ to indicate that these generation intervals are measured from infectors who developed symptoms at the same time.

The symptom-based generation-interval distribution describing \eref{serial} gives a biased picture because infectors who developed symptoms at the same time will have shorter incubation periods (when epidemic is growing) and therefore transmit earlier.
This symptom-based generation-interval distribution depends on the backward incubation-period distribution:
\begin{align}
f_{G, \mathrm{symptom}}(\tau) &= \int_0^\infty f_{G|I}(\tau|x) b_I(x) \dx,
\end{align}
where $f_{G|I}(\tau|x)$ represents the forward generation-interval distribution conditional on a known value of the incubation period, $x$.
Instead, the forward generation-interval distribution measured from a cohort of individuals who were infected at the time is expected to provide reliable estimates of the distribution across individuals (because their incubation-period distribution is expected to remain constant over time):
\begin{align}
f_{G, \mathrm{inf}}(\tau) &= \int_0^\infty f_{G|I}(\tau|x) f_I(x) \dx.
\label{eq:meangen}
\end{align}

When epidemic is growing is exponentially, we have two opposing effects affecting the relationship between the mean serial and generation interval.
First, infectors in a given cohort are more likely to have shorter incubation periods than their infectees on average, $\mathbb E[\tau_{i, 1}] < \mathbb E[\tau_{i, 2}]$, causing the mean forward serial interval to be longer than the mean symptom-based generation interval ($\mathbb E[\tau_s] > \mathbb E[\tau_{g, \mathrm{symp}}]$).
Second, the mean symptom-based generation interval will be shorter than the mean infection-based generation interval: $E[\tau_{g, \mathrm{inf}} > \mathbb E[\tau_{g, \mathrm{symp}}]$.
Therefore, the difference between the mean serial interval and the mean infection-based generation interval is difficult to predict in general; in most cases, however, we expect the former effect to dominate, causing the mean serial interval to be longer than the mean infection-based generation interval: $\mathbb E[\tau_s] > E[\tau_{g, \mathrm{inf}}$ \citep{park2021forward}.
For simplicity, we will use the term ``forward generation-interval'' to refer to the infection-based generation-interval distribution (measured from a cohort of infectors who were infected at the same infection time), and drop the subscript $\mathrm{inf}$.

We model the forward incubation-period $f_I(\tau)$ and generation-interval $f_G(\tau)$ distributions using a bivariate lognormal distribution.
The joint distribution is parameterized by log means, $\mu_I$ and $\mu_G$, log variances, $\sigma_I^2$ and $\sigma_G^2$, and the correlation coefficient on a log scale $\rho$.
Thus, the forward generation-interval distribution conditional on the incubation period $f_{G|I}(\tau|\tau_{i,1})$ has a log mean of $\mu_G + \sigma_G \rho (\log(\tau_{i, 1}) - \mu_I)/\sigma_I$ and a log variance of $\sigma_G^2 (1 - \rho^2)$.
Assuming that the incidence of infection is changing exponentially at rate $r$, the forward serial-interval distribution $f_S(\tau)$ for a cohort of infectors who developed symptoms at time $t = 0$ can be calculated by integrating across infection time of the infector $\alpha_1 < 0$ and of the infectee $\alpha_2 > \alpha_1$ \citep{park2021forward}:
\begin{equation}
f_S(\tau) = \frac{1}{\phi} \int_{-\infty}^0\int_{\alpha_1}^\tau \exp(r \alpha_1) f_{G|I}(\alpha_2 - \alpha_1|- \alpha_1) f_I(- \alpha_1) f_I(\tau - \alpha_2) \dd \alpha_2 \dd \alpha_1,
\label{eq:forwardserial}
\end{equation}
where $\phi$ is a normalization constant chosen so that $\int f_S(x) \dx = 1$;
$-\alpha_1$ corresponds to the incubation period of the infector;
$\alpha_2 - \alpha_1$ corresponds to the generation interval;
and $\tau - \alpha_2$ corresponds to the incubation period of the infectee.

For a given value of $r$, we first estimate the forward incubation-period distribution from the backward distribution, previously estimated by \cite{backer2021omicron}, using \eref{forward}.
We then approximate the forward incubation-period distribution with a lognormal distribution by matching the mean and standard deviation.
Using this incubation-period distribution, we fit \eref{forwardserial} to the observed serial-interval data by minimizing the negative log-likelihood.
We then calculate the mean forward generation interval using \eref{meangen} and approximate the 95\% confidence interval using the Delta method.
We assume $\rho = 0.75$ throughout based on \cite{sender2021unmitigated}---since we do not have individual-level data on infection and symptom onset times, we expect this parameter to be unidentifiable in practice.
In Supplementary Material, we explore how assumptions about $\rho$ affect inferences of the generation-interval distribution.

\subsection{Estimating instantaneous reproduction number}

We use our estimates of the generation-interval distributions to infer instantaneous reproduction numbers \Rt\ of the Delta and Omicron variant, as well as the ratio between two reproduction numbers.
Estimating the instantaneous reproduction number---defined as the average number of secondary infections that a primary case will generate if epidemiological conditions remain constant \citep{fraser2007estimating}---requires the intrinsic generation-interval distribution $g(\tau)$:
% \jd{We should think about this, too -- is it really just the forward if it's \Rt?}
% \swp{Not sure what you mean... during exponential growth, forward = intrinsic...}
\begin{equation}
\Rt = \frac{i(t)}{\int_0^\infty i(t-x) g(x) \dx},
\end{equation}
where $i(t)$ represents incidence of infection.
Here, we approximate the intrinsic generation-interval distribution with the forward generation-interval that we estimate for week 50---when epidemic is growing or decaying exponentially, we expect the forward generation-interval to be a good proxy for the intrinsic generation-interval distribution \citep{champredon2015intrinsic, park2020inferring}.
Incidence of infection is approximated by shifting the smoothed case trajectories by one week to account for reporting delays.
This method of approximating incidence of infection assumes a fixed delay between infection and case reporting;
in practice, deconvolution is required to accurately estimate the incidence of infection \citep{goldstein2009reconstructing}.
Case reports are also sensitive to changes in testing behavior, and therefore our estimates of $\Rt$ must be interpreted with care.
Confidence intervals are calculated by sampling parameters of the smoothed case trajectories as well as the generation-interval distributions from multivariate normal distributions and repeating the analysis 1000 times.

\section{Results}

\fref{epidemic} summarizes the epidemiological context in the Netherlands during the study period.
The first known Omicron case in the Netherlands was sampled on 19 November 2021 \citep{backer2021omicron}, during a period when COVID-19 incidence was decreasing (\fref{epidemic}A).
As the Omicron variant continued to spread and increase in proportion (\fref{epidemic}B), the number of COVID-19 cases started to increase (\fref{epidemic}A).
Multiplying the proportion of each variant with the number of reported COVID-19 cases further allows us to estimate the epidemiological dynamics of each (\fref{epidemic}C).
The number of COVID-19 cases caused by the Delta variant continued to decrease throughout the study period with time-varying growth rates decreasing from $r \approx -0.01/\mathrm{day}$ to $r \approx -0.09/\mathrm{day}$ by the week of January 16, 2022, and increasing back up to $r \approx -0.04/\mathrm{day}$.
The number of COVID-19 cases caused by the Omicron variant increased rapidly but decelerated over time with time-varying growth rates decreasing from $r=0.18/\mathrm{day}$ on the week of December 19, 2021, to $r=0.04/\mathrm{day}$.
Finally, we find that the growth-rate difference between the Delta and Omicron variants decreased over time.

\begin{figure}[!ht]
\includegraphics[width=\textwidth]{figure_epidemic.pdf}
\caption{
\textbf{Epidemic dynamics on the Delta and Omicron variants in the Netherlands.}
(A) Daily numbers of reported COVID-19 cases in the Netherlands (points).
The solid line represents the 7-day moving average.
Data are publicly available on \url{https://data.rivm.nl/covid-19/}.
(B) Proportion of SARS-CoV-2 variants detected from the Netherlands. Data are publicly available on \url{https://www.rivm.nl/coronavirus-covid-19/virus/varianten}.
(C) Weekly numbers of COVID-19 cases caused by the Delta (black points) and Omicron (orange triangles) variants are estimated by multiplying the weekly numbers of cases (A) with the proportion of each variant (B).
Solid lines and shaded areas represent fitted lines and corresponding 95\% confidence intervals using generalized additive model.
(D) Estimated growth rates of the Delta (black) and Omicron variants (orange) and their growth-rate differences (purple).
Lines and shaded areas represent medians and corresponding 95\% confidence intervals.
Growth rates are estimated by taking the derivative of the generalized additive model estimates.
\label{fig:epidemic}
}
\end{figure}

For a cohort of individuals who developed symptoms between 1 December 2021 and 2 January 2022, \citep{backer2021omicron} found longer mean (backward) incubation period for the Delta variant than for the Omicron variant (\fref{incubation}A).
However, these measurements were done during a period when the incidence of Omicron was increasing while the increasing of Delta was decreasing (\fref{epidemic}).
Thus, dynamical bias would be expected to lead to shorter observed (backward) incubation periods in Omicron, and longer observed incubation periods in Delta. 
When we account for these growth-rate differences and re-estimate the forward incubation periods, we find that both variants have similar incubation-period distributions (\fref{incubation}B)---for illustrative purposes, we assume $r=-0.05/\mathrm{day}$ and $r=0.15/\mathrm{day}$ for the Delta and Omicron variants, respectively.
Although the exact estimate of the mean forward incubation periods of both variants are sensitive to the assumed growth/decay rates, we find similar means across a plausible ranges of growth rates with unclear differences between two variants (\fref{incubation}C).
% \jd{Do we need the ff.~s.? What does it add to the Fig?}
% \swp{I think people like to see actual values...}
For example, the mean forward incubation period of the Delta variant changes from 3.8 days (95\% CI: 3.5--4.1 days) to 4.4 days (95\% CI: 4.0--4.8 days) as we change the assumed values of $r$ from $-0.1/\mathrm{days}$ to $0/\mathrm{days}$, while
the mean forward incubation period of the Omicron variant changes from 3.8 days (95\% CI: 3.4--4.4 days) to 4.5 days (95\% CI: 3.9--5.5 days) as we change the assumed values of $r$ from $0.1/\mathrm{days}$ to $0.2/\mathrm{days}$.

\begin{figure}[!th]
\includegraphics[width=\textwidth]{figure_incubation.pdf}
\caption{
\textbf{Observed and corrected differences in incubation-period distributions of Delta and Omicron variants.}
(A) Posterior median estimates of the observed (backward) incubation periods of the Delta (black) and Omicron (orange) variants by \cite{backer2021omicron}.
(B) Forward incubation-period distributions assuming $r=-0.05/\mathrm{day}$ and $r=0.15/\mathrm{day}$ for the Delta (black) and Omicron (orange) variants, respectively.
(C) Corrected estimates of the forward incubation-period distributions for different assumptions about the growth rates of the Delta (black, solid lines) and Omicron variants (orange, dashed lines).
Middle lines represent median estimates, and lower and upper lines represent corresponding 95\% confidence intervals.
\label{fig:incubation}
}
\end{figure}

Our corrected estimates of the forward incubation-period distributions further allow us to infer the forward generation-interval distributions.
For illustrative purposes, we first focus on within-household serial intervals from infectors who developed symptoms during week 50 (13-â€“19 December, 2021)---\citep{backer2021omicron} reported shorter mean serial interval of the Omicron variant (3.5 days) than that of the Delta variant (4.1 days) for this cohort (\fref{serial}A).
When we account for growth-rate differences (assuming $r=-0.05/\mathrm{day}$ and $r=0.15/\mathrm{day}$ for the Delta and Omicron variants, respectively), the estimated mean forward generation interval exhibits a larger difference (\fref{serial}B): 3.3 days (95\% CI: 2.8--3.7 days) for the Omicron variant and 4.2 days (95\% CI: 4.0--4.4 days).
Notably, both variants have similar mode, but the transmissibility of the omicron variant is estimated to decay much faster (\fref{serial}B).
Note that the mean forward generation interval of the Omicron (respectively, Delta) variant is shorter (longer) than its mean serial interval due to the effect of a growing (declining) epidemic.
The estimated differences of the mean generation interval increase if we assume that generation intervals and incubation periods are less correlated (and therefore, lower values of $\rho$; Supplementary Figure S1).
On the other hand, neglecting growth-rate differences (i.e., assuming $r= 0/\mathrm{day}$ for both variants) leads to the underestimation of these differences (Supplementary Figure S2): 3.5 days (95\% CI: 3.1--3.9 days) for the Omicron variant and 4.1 days (95\% CI: 3.9--4.3 days).

We then estimate the mean forward generation intervals for all other cohorts, stratified by the week of symptom onset (weeks 50 and 51) and the type of transmission (within and between household(s)).
As before (see \fref{incubation}C), we repeat the analysis for different values of growth rates for the Delta ($r=-0.1/\mathrm{days}$ to $0/\mathrm{days}$) and Omicron ($r=0.1/\mathrm{days}$ to $0.2/\mathrm{days}$) variants and plot the maximum likelihood estimates and the associated CIs.
We estimate shorter mean forward generation intervals for the Omicron variant across all stratification (\fref{serial}C), but the differences in the mean generation intervals are unclear for between-household pairs.
Consistent with the original study, which also reported shorter mean forward serial intervals for between-household pairs \citep{backer2021omicron}, we estimate shorter mean forward generation intervals for between-household pairs.
We also estimate a reduction in the mean forward generation intervals from week 50 to week 51. 

\begin{figure}[!th]
\includegraphics[width=\textwidth]{figure_compare.pdf}
\caption{
\textbf{Estimated forward generation-interval distributions of Delta and Omicron variants.}
(A) Observed and fitted forward serial-interval distributions for within-household transmission pairs in the Netherlands for the Delta (black) and Omicron (orange) variants \citep{backer2021omicron}.
Serial intervals are calculated for infectors who developed symptoms on week 50 (13 and 19 December, 2021).
Points represent the observed data.
Lines represent the fitted lines assuming $r=-0.05/\textrm{day}$ for the Delta variant and $r=0.15/\textrm{day}$ for the Omicron variant. 
Bivariate lognormal distributions with correlation coefficient of 0.75 are used to model relationships between incubation and generation intervals.
(B) Estimated forward generation-interval distributions for within-household transmission pairs in the Netherlands.
(C) Sensitivity of the mean generation-interval estimates to assumed growth rates of the Delta (black, solid lines) and Omicron variants (orange, dashed lines) stratified by the week of infectors' symptom onset and the type of transmission pairs.
\label{fig:serial}
}
\end{figure}

Accounting for differences in the generation-interval distributions, we estimate that the reproduction number of the Omicron variant decreased from 1.83 (95\% CI: 1.65--2.05) to 1.17 (95\% CI: 1.00--1.36) between December 12, 2021, and January 23, 2022(\fref{reproduction}A).
On the other hand, the reproduction number of the Delta variant decreased from 0.89 (95\% CI: 0.82--0.97) to 0.68 (95\% CI: 0.62--0.74) between December 5, 2021, and January 9, 2022, and increased back up to 0.82 (95\% CI: 0.72--0.93) by January 23, 2022 (\fref{reproduction}A).
We estimate the reproduction number ratios stayed roughly constant at around 2.2 (95\% CI: 2.0--2.5) between December 12--26, 2021, and slowly decreased to 1.4 (95\% CI: 1.2--1.7).
However, if we neglect differences in the generation-interval distributions and solely rely on the generation-interval-distribution estimate for the Delta variant, we over-estimate the reproduction number of the Omicron variant and therefore is transmission advantage (\fref{reproduction}B).
In this case, the reproduction ratio decreases from 2.5 (95\% CI: 2.2--2.8) to 1.5 (95\% CI: 1.2--1.8), corresponding to roughly 7--13\% bias.

In both cases, the decrease in the reproduction number ratio coincides with the decrease in the reproduction number of the Omicron variant, implying that epidemiological changes driving the dynamic had larger effects on the transmission of the Omicron variant than on the transmission of Delta variant;
a larger reduction in the reproduction number of the Omicron variant also caused its growth rate to decrease faster, causing changes in the growth-rate difference (\fref{epidemic}D).


\begin{figure}[!th]
\includegraphics[width=\textwidth]{figure_reproduction_advantage.pdf}
\caption{
\textbf{Estimated time-varying reproduction number advantages of the Omicron variant.}
(A) Estimated instantaneous reproduction numbers and their ratios over time while accounting for differences in the generation-interval distributions.
(B) Estimated instantaneous reproduction numbers and their ratios over time while assuming identical generation-interval distributions.
The instantaneous reproduction number of each variant is estimated using the renewal equation by shifting the smoothed case curves by one week (\fref{epidemic}C).
The intrinsic generation-interval distribution is approximated by the maximum likelihood estimates of the generation-interval distributions for within-household transmission pairs based on $r=-0.05$ for the Delta variant (black) and $r=0.15$ for the Omicron variant (orange).
Purple lines represent the ratio between the effective reproduction numbers of the Delta and Omicron variants.
Lines and shaded regions represent medians and corresponding 95\% confidence intervals.
\label{fig:reproduction}
}
\end{figure}

\section{Discussion}

We compare estimates of the forward incubation-period and generation-interval distributions of the Delta and Omicron variants from the Netherlands.
The original analysis detailing the data set previously reported shorter mean incubation period and serial interval for the Omicron variant \citep{backer2021omicron}.
Accounting for differences in epidemic growth rates, we find similar incubation-period distributions for both variants but a considerably shorter (0.5--0.9 days) mean generation interval for the Omicron variant.
The mean forward generation interval of both variants further decreased between week 50 (13--19 December, 2021) and week 51 (20--26 December, 2021).
Finally, we estimate that the transmission advantage of the Omicron variant decreased from 2.2-fold to 1.4-fold between early December and late January. 
Neglecting differences in the generation-interval distributions can result in $\approx 10\%$ bias in estimates of the transmission advantage.

The generation-interval distribution describes changes in the individual-level transmission dynamics over the course of infection and therefore provides crucial information for epidemic control.
A few studies have estimated the generation-interval distributions of SARS-CoV-2 infections from serial-interval data, but most of them neglect the effects of epidemic growth rates \citep{ganyani2020estimating,he2020temporal,zhao2021estimating,hart2022generation}---these practices can be largely attributed to historical work that concluded that serial and generation intervals have the same means based on the assumption that infectors and infectees have identical incubation-period distributions \citep{svensson2007note,britton2019estimation,lehtinen2021relationship}.
Here, we build on our previous work \citep{park2021forward}, which demonstrated theoretically that forward serial-interval distributions depends on epidemic growth rates, and further confirm that estimates of the forward generation-interval distributions are indeed sensitive to epidemic growth rates.
Accounting for the growth-rate effects is especially important when comparing serial and generation intervals of different variants or from different time periods.
These effects are also pertinent to all epidemiological inferences of past events from a cohort of infected individuals who experienced the succeeding event at the same time---this includes inferences of other delay distributions, such as incubation-period distributions, as well as viral load trajectories \citep{hay2021estimating}.

To our knowledge, our study is the first to estimate the generation-interval distribution of the Omicron variant.
Although we estimate a shorter mean generation interval for the Omicron variant, we find the generation-interval distribution of the Omicron and Delta variants have similar modes (around 2.5 days), implying that the realized transmissibility of the Omicron variant decays faster.
We tentatively hypothesize that these differences may be primarily driven by the network effect: a higher reproduction numbers of the Omicron variant leads to faster susceptible depletion among close contacts, which in turn prevents long generation intervals from generating infections \citep{park2020inferring,hart2022generation}. 
While the network effect is expected to be strongest among household contacts, it is also applicable to other forms of contact structures that involve repeated contacts between the same group of individuals (because only the first infectious contact results in infection).
The network effect may also explain a decrease in the mean generation interval between week 50 and 51, especially among household transmission pairs, as a higher proportion of individuals within households would have been infected with either the Delta or Omicron variants.
Other factors, such as more stringent intervention measures against the Omicron variant \citep{backer2021omicron} and shorter clearance phase of the Omicron variant \citep{hay2022viral}, also likely contributed to shortening of the generation intervals.

While our study indicate that the Omicron variant has a shorter mean realized generation interval than that of the Delta variant, it is still uncertain how much their infectiousness profiles differ intrinsically.
In particular, similarities in the incubation-period distributions of the Delta and Omicron variants suggest that the differences in their intrinsic infectiousness profile may be smaller than the estimated differences in their realized generation-interval distributions.
Nonetheless, our estimates of the realized generation-interval distributions better describe the epidemic dynamics, implicitly accounting for intervention and behavioral effects, and are therefore should be used to estimate current reproduction numbers (rather than a counterfactual intrinsic generation-interval distribution, which may have a longer mean).

Our study also has important implications for estimating transmission advantages of new SARS-CoV-2 variants.
In the example we consider, neglecting differences in the generation-interval distributions leads to $\approx 10\%$ bias in the estimates of the reproduction number ratios; however, the degree of ratio is expected to be sensitive to the assumed generation-interval distribution of the resident variant.
For example, \cite{pearson2021bounding} estimated a much higher reproduction ratios ($> 4$ fold) in South Africa but also assumed a longer mean generation interval for the Delta and Omicron variants (6.4 vs 5.2 days, respectively).
With our generation-interval estimates, we estimate that the reproduction number ratio of 2.8 assuming $r=-0.06$ and $r=0.26$ for the Delta and Omicron variants, respectively---these growth rates were chosen to match the 4-fold reproduction number ratios with the estimated growth-rate differences of $0.32/\mathrm{day}$ for the Gauteng province, South Africa \cite{pearson2021bounding}.
We also show that both growth-rate differences and the reproduction number ratios decreased over time---this result further corroborates are earlier theoretical framework, which showed that growth-rate differences changes over the course of an epidemic even when the reproduction number ratios remain constant \citep{park2021roles}.

We primarily rely on case data to understand epidemic patterns of the Delta and Omicron variants.
In doing so, we implicitly assume that the delay between infection and reports is fixed.
However, changes in case trajectories are sensitive to testing patterns and therefore may not accurately reflect patterns of infections.
While this limitation does not affect our generation-interval estimates, our inferences of the transmission advantages of the Omicron variant should be interpreted with care.

Monitoring changes in key epidemiological parameters is critical to understanding the evolution of SARS-CoV-2 and predicting its future dynamics \citep{kraemer2021monitoring}.
Our study synthesizes previously developed theoretical framework on serial- and generation-interval distributions and presents methodological advances in monitoring epidemiological parameters;
however, uncertainty remains in the intrinsic infectiousness profiles of SARS-CoV-2 variants, especially among asymptomatically infected individuals \citep{park2020time}.
Future studies extending our framework and combining more detailed epidemiological data will be critical to narrowing down these uncertainties.

\pagebreak

\section*{Supplementary Materials}
\setcounter{figure}{0}
\renewcommand{\thefigure}{S\arabic{figure}}

\begin{figure}[!th]
\includegraphics[width=\textwidth]{figure_compare_rho.pdf}
\caption{
\textbf{Sensitivity of the estimates of the mean generation interval to the assumed values of the correlation coefficient of the lognormal distribution.}
Lines represent maximum likelihood estimates and the corresponding 95\% confidence intervals for the Delta (black, solid lines) and Omicron variants (orange, dashed lines).
For illustrative purposes we use within-household serial-interval data from the cohort of infectors who developed symptoms during week 50.
}
\end{figure}

\pagebreak

\begin{figure}[!th]
\includegraphics[width=\textwidth]{figure_compare_r_0.pdf}
\caption{
\textbf{Estimated forward generation-interval distributions of Delta and Omicron variants while neglecting growth-rate differences.}
See Figure 3 in the main text for figure caption.
}
\end{figure}

\pagebreak

\bibliography{omicron.bib}

\end{document}
